Peishan Qiu

1.0k total citations · 1 hit paper
20 papers, 712 citations indexed

About

Peishan Qiu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Peishan Qiu has authored 20 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Peishan Qiu's work include Ferroptosis and cancer prognosis (6 papers), MicroRNA in disease regulation (4 papers) and COVID-19 Clinical Research Studies (3 papers). Peishan Qiu is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), MicroRNA in disease regulation (4 papers) and COVID-19 Clinical Research Studies (3 papers). Peishan Qiu collaborates with scholars based in China and Netherlands. Peishan Qiu's co-authors include Haizhou Wang, Fan Wang, Qiu Zhao, Zhang Zhang, Jiayan Nie, Jun Fang, Huijie Yang, Xiaojia Chen, Meng Zhang and Yunjiao Zhou and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Advanced Science.

In The Last Decade

Peishan Qiu

20 papers receiving 693 citations

Hit Papers

Consumption of ultra-processed foods and health outcomes:... 2020 2026 2022 2024 2020 100 200 300

Peers

Peishan Qiu
Peishan Qiu
Citations per year, relative to Peishan Qiu Peishan Qiu (= 1×) peers Riyadh Saif-Ali

Countries citing papers authored by Peishan Qiu

Since Specialization
Citations

This map shows the geographic impact of Peishan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peishan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peishan Qiu more than expected).

Fields of papers citing papers by Peishan Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peishan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peishan Qiu. The network helps show where Peishan Qiu may publish in the future.

Co-authorship network of co-authors of Peishan Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Peishan Qiu. A scholar is included among the top collaborators of Peishan Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peishan Qiu. Peishan Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Peishan, Youwei Wang, Xiaoyu Chen, et al.. (2024). Revitalizing gut barrier integrity: role of miR-192-5p in enhancing autophagy via Rictor in enteritis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 327(3). G317–G332. 1 indexed citations
2.
Qiu, Peishan, Jingwen Ai, Bo Liu, et al.. (2024). Endogenous retrovirus activation: potential for immunology and clinical applications. National Science Review. 11(4). nwae034–nwae034. 7 indexed citations
3.
Qiu, Peishan, Ying Chang, Xiaoyu Chen, et al.. (2024). Dihydroartemisinin Modulates Enteric Glial Cell Heterogeneity to Alleviate Colitis. Advanced Science. 11(35). e2403461–e2403461. 5 indexed citations
4.
Chen, Danyang, Yangyang Zhang, Haizhou Wang, et al.. (2024). Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer. Scientific Reports. 14(1). 4459–4459. 6 indexed citations
6.
Qiu, Peishan, Xiaoyu Chen, Cong Xiao, et al.. (2023). Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer. Journal of Cancer Research and Clinical Oncology. 149(9). 6411–6434. 7 indexed citations
7.
Qiu, Peishan, Daojiang Li, Xiaoyu Chen, et al.. (2023). The Eph/ephrin system symphony of gut inflammation. Pharmacological Research. 197. 106976–106976. 5 indexed citations
9.
Zhou, Yunjiao, Zhenwei Yang, Hailin Zhang, et al.. (2022). DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(4). 166353–166353. 19 indexed citations
10.
Qiu, Peishan, Lan Liu, Jun Fang, et al.. (2021). Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis. Frontiers in Pharmacology. 12. 769718–769718. 11 indexed citations
11.
Zhou, Rui, Peishan Qiu, Haizhou Wang, et al.. (2021). Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease. Aging. 13(3). 4634–4646. 28 indexed citations
12.
Li, Hai-Ou, Yunjiao Zhou, Haizhou Wang, et al.. (2021). DOC‐2/DAB2 interactive protein destabilizes c‐Myc to impair the growth and self‐renewal of colon tumor‐repopulating cells. Cancer Science. 112(11). 4593–4603. 8 indexed citations
13.
Qiu, Peishan, Yunjiao Zhou, Fan Wang, et al.. (2020). Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clinical and Experimental Research. 32(9). 1869–1878. 87 indexed citations
14.
Chen, Xiaojia, Zhang Zhang, Huijie Yang, et al.. (2020). Consumption of ultra-processed foods and health outcomes: a systematic review of epidemiological studies. Nutrition Journal. 19(1). 86–86. 335 indexed citations breakdown →
15.
Qiu, Peishan, Haizhou Wang, Mengna Zhang, et al.. (2020). FATP2-targeted therapies — A role beyond fatty liver disease. Pharmacological Research. 161. 105228–105228. 39 indexed citations
16.
Zhang, Meng, Zhou Zhou, Yunjiao Zhou, et al.. (2020). Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer. Cancer Cell International. 20(1). 510–510. 5 indexed citations
17.
Li, Haiou, Yunjiao Zhou, Haizhou Wang, et al.. (2020). Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. Frontiers in Immunology. 11. 1169–1169. 88 indexed citations
18.
Wang, Haizhou, Peishan Qiu, Jing Liu, Fan Wang, & Qiu Zhao. (2020). The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 44(5). 653–661. 41 indexed citations
19.
Zhang, Mengna, Yunjiao Zhou, Haiou Li, et al.. (2020). COVID-19: gastrointestinal symptoms from the view of gut–lung axis. European Journal of Gastroenterology & Hepatology. 33(5). 610–612. 7 indexed citations
20.
Wang, Haizhou, Peishan Qiu, Mengna Zhang, et al.. (2019). SET nuclear proto-oncogene gene expression is associated with microsatellite instability in human colorectal cancer identified by co-expression analysis. Digestive and Liver Disease. 52(3). 339–346. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026